(Q46884256)

English

Phase 1 randomized double-blind safety and immunogenicity trial of Plasmodium falciparum malaria merozoite surface protein FMP1 vaccine, adjuvanted with AS02A, in adults in western Kenya

scientific article published on 7 December 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16388879

Phase 1 randomized double-blind safety and immunogenicity trial of Plasmodium falciparum malaria merozoite surface protein FMP1 vaccine, adjuvanted with AS02A, in adults in western Kenya (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16388879

0 references

phase I clinical trial

0 references

Plasmodium falciparum

0 references

0 references

1 reference

based on heuristic

inferred from title

Plasmodium falciparum malaria

1 reference

based on heuristic

inferred from title

malaria vaccine

1 reference

based on heuristic

inferred from title

object named as

Kent E Kester

16

0 references

20

object named as

Janet Wittes

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

Christian F Ockenhouse

17

object named as

Christian F Ockenhouse

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16388879

13

object named as

Evelina Angov

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16388879

D. Gray Heppner

21

object named as

D Gray Heppner

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16388879

Denise M. McKinney

5

object named as

Denise McKinney

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16388879

4

object named as

Joram Siangla

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16388879

Kathryn M Tucker

9

object named as

Kathryn Tucker

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16388879

19

object named as

Carter L Diggs

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16388879

14

object named as

Amanda Leach

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16388879

Lorraine A Soisson

10

object named as

Lorraine Soisson

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16388879

Jessica B Milman

8

object named as

Jessica Milman

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16388879

MSP-1 Malaria Vaccine Working Group

22

object named as

MSP-1 Malaria Vaccine Working Group

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16388879

1

object named as

José A Stoute

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16388879

author name string

Joash Gombe

2

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16388879

Mark R Withers

3

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16388879

Melanie Onyango

6

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16388879

James F Cummings

7

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16388879

V Ann Stewart

11

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16388879

Jeffrey A Lyon

12

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16388879

Joe Cohen

15

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16388879

Carolyn A Holland

18

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16388879

language of work or name

0 references

publication date

7 December 2005

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16388879

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16388879

25

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16388879

1

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16388879

176-184

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16388879

Roll Back Malaria: a failing global health campaign

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.037

7 January 2021

The economic and social burden of malaria

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.037

7 January 2021

The major merozoite surface protein as a malaria vaccine target

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.037

7 January 2021

Protective antigens of rodent and human bloodstage malaria.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.037

7 January 2021

Secondary processing of the Plasmodium falciparum merozoite surface protein-1 (MSP1) by a calcium-dependent membrane-bound serine protease: shedding of MSP133 as a noncovalently associated complex with other fragments of the MSP1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.037

7 January 2021

Fine specificity of serum antibodies to Plasmodium falciparum merozoite surface protein, PfMSP-1(19), predicts protection from malaria infection and high-density parasitemia

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.037

7 January 2021

Clinical immunity to Plasmodium falciparum malaria is associated with serum antibodies to the 19-kDa C-terminal fragment of the merozoite surface antigen, PfMSP-1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.037

7 January 2021

Human antibodies to the 19kDa C-terminal fragment of Plasmodium falciparum merozoite surface protein 1 inhibit parasite growth in vitro

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.037

7 January 2021

A recombinant vaccine expressed in the milk of transgenic mice protects Aotus monkeys from a lethal challenge with Plasmodium falciparum

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.037

7 January 2021

Efficacy of two alternate vaccines based on Plasmodium falciparum merozoite surface protein 1 in an Aotus challenge trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.037

7 January 2021

The clinical-grade 42-kilodalton fragment of merozoite surface protein 1 of Plasmodium falciparum strain FVO expressed in Escherichia coli protects Aotus nancymai against challenge with homologous erythrocytic-stage parasites

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.037

7 January 2021

Development and pre-clinical analysis of a Plasmodium falciparum Merozoite Surface Protein-1(42) malaria vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.037

7 January 2021

Pre-clinical evaluation of the malaria vaccine candidate P. falciparum MSP1(42) formulated with novel adjuvants or with alum

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.037

7 January 2021

Phase I safety and immunogenicity trial of FMP1/AS02A, a Plasmodium falciparum MSP-1 asexual blood stage vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.037

7 January 2021

Characterization of malaria transmission by Anopheles (Diptera: Culicidae) in western Kenya in preparation for malaria vaccine trials

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.037

7 January 2021

Sequence heterogeneity of the C-terminal, Cys-rich region of the merozoite surface protein-1 (MSP-1) in field samples of Plasmodium falciparum

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.037

7 January 2021

Malaria and anemia

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.037

7 January 2021

Loss of red blood cell-complement regulatory proteins and increased levels of circulating immune complexes are associated with severe malarial anemia

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.037

7 January 2021

New World monkey efficacy trials for malaria vaccine development: critical path or detour?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.037

7 January 2021

Anemia in parasite- and recombinant protein-immunized aotus monkeys infected with Plasmodium falciparum.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.037

7 January 2021

The ears of the hippopotamus: manifestations, determinants, and estimates of the malaria burden

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.037

7 January 2021

based on heuristic

inferred from DOI database lookup

Age-dependent acquired protection against Plasmodium falciparum in people having two years exposure to hyperendemic malaria

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.037

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical disease, immunity and protection against Plasmodium falciparum malaria in populations living in endemic areas

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.037

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2005.11.037

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16388879

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16388879

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46884256&oldid=2136196423"